Medivie Therapeutic Ltd (MDVI) - Total Liabilities

Latest as of June 2021: ILA9.13 Million ILA ≈ $24.49K USD

Based on the latest financial reports, Medivie Therapeutic Ltd (MDVI) has total liabilities worth ILA9.13 Million ILA (≈ $24.49K USD) as of June 2021. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Medivie Therapeutic Ltd cash conversion from operations to assess how effectively this company generates cash.

Medivie Therapeutic Ltd - Total Liabilities Trend (2010–2020)

This chart illustrates how Medivie Therapeutic Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Medivie Therapeutic Ltd to evaluate the company's liquid asset resilience ratio.

Medivie Therapeutic Ltd Competitors by Total Liabilities

The table below lists competitors of Medivie Therapeutic Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Enlivex Therapeutics Ltd TA:ENLV	Israel	ILA3.46 Million
SDCL EDGE Acquisition Corporation NYSE:SEDA	USA	$110.33 Million
Cobra Resources PLC LSE:COBR	UK	GBX245.21K
Upsellon Brands Holdings Ltd TA:CHR	Israel	ILA2.01 Million
SDM SE XETRA:75S	Germany	€12.80 Million
CORELENS S.A. ZY -10 F:9GK	Germany	€20.84 Million
Hepion Pharmaceuticals Inc NASDAQ:HEPA	USA	$402.40K

Liability Composition Analysis (2010–2020)

This chart breaks down Medivie Therapeutic Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Medivie Therapeutic Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.36	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-2.95	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.95	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medivie Therapeutic Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medivie Therapeutic Ltd (2010–2020)

The table below shows the annual total liabilities of Medivie Therapeutic Ltd from 2010 to 2020.

Year	Total Liabilities	Change
2020-12-31	ILA8.46 Million ≈ $22.69K	+11.21%
2019-12-31	ILA7.61 Million ≈ $20.40K	+76.26%
2018-12-31	ILA4.32 Million ≈ $11.58K	+25.23%
2017-12-31	ILA3.45 Million ≈ $9.24K	+91.02%
2016-12-31	ILA1.80 Million ≈ $4.84K	+63.35%
2015-12-31	ILA1.10 Million ≈ $2.96K	-35.90%
2014-12-31	ILA1.72 Million ≈ $4.62K	-15.90%
2013-12-31	ILA2.05 Million ≈ $5.50K	+40.70%
2012-12-31	ILA1.46 Million ≈ $3.91K	-84.60%
2011-12-31	ILA9.46 Million ≈ $25.36K	-0.89%
2010-12-31	ILA9.55 Million ≈ $25.59K	--

About Medivie Therapeutic Ltd

TA:MDVI Israel Machinery, Tools, Heavy Vehicles, Trains & Ships

Market Cap

$516.77K

ILA192.76 Million ILA

Market Cap Rank

#30535 Global

#458 in Israel

Share Price

ILA67.00

Change (1 day)

+10.56%

52-Week Range

ILA17.00 - ILA138.00

All Time High

ILA140000.00